INTRODUCTION
Recently, the diagnostic criteria for the diagnosis of immune-mediated acquired demyelinating syndromes (ADS) of the central nervous system (CNS), including paediatric multiple sclerosis (MS), have been revised by the International Paediatric Multiple Sclerosis Study Group (IPMSSG). 1 The new definitions aim to improve consistency in terminology in the heterogeneous group of paediatric demyelinating disorders. They incorporate the 2010 revised McDonald criteria for MS. 2 Diagnosing MS earlier in the disease course is favourable because disease-modifying treatment (DMT) is also beneficial in children with MS. 3 Previous studies already showed that the 2010 McDonald MRI criteria, which allow diagnosis at disease onset, are useful for early MS diagnosis in children. [4] [5] [6] [7] [8] But they recommended to be cautious when applying these MRI criteria to young children with acute disseminated encephalomyelitis (ADEM). 4 6 Therefore, the IPMSSG included in the revised 2012 definitions that the 2010 McDonald MRI criteria for dissemination in time (DIT) and dissemination in space (DIS) cannot be applied at first event in children with ADEM and children younger than 12 years old. 1 In the new IPMSSG consensus definitions, diagnostic criteria for ADEM and neuromyelitis optica (NMO) have been sharpened and the term recurrent ADEM is excluded. Our aim was to evaluate the new 2012 IPMSSG consensus definitions in our clinical cohort of prospectively included children with ADS.
METHODS

Patients and definitions
Children younger than 18 years, who presented with a first episode of acquired demyelination of the CNS between January 2007 and April 2013, were prospectively included. All children were identified by the Dutch Study Group for Paediatric MS, which consists of paediatric neurologists in 13 major paediatric neurology centres in the Netherlands, or the children were identified by Dutch paediatricians who participate in the NSCK (Netherlands Paediatric Surveillance Unit) as has been described elsewhere. 9 Children were eligible for this study when a cerebral MRI scan had been obtained within 90 days after first onset of symptoms. All patients had a minimum follow-up time of 2 years, unless they were diagnosed with definite MS. MS diagnosis could be made either on evidence of a second clinical attack at least 30 days after the initial attack or on MRI evidence of DIT within 2 years. Patients were classified as MS, ADEM, clinically isolated syndrome, NMO or other relapsing demyelinating disorders according to the 2007 10 
Statistical analysis
Analyses were performed using SPSS V.20.0. Patient characteristics were compared using χ 2 and Student t tests. Test characteristics of the 2007 and 2012 diagnostic criteria (ie, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy) were calculated using clinical definite multiple sclerosis (CDMS) as endpoint. Children with MS diagnosis based on MRI criteria who started DMT before CDMS diagnosis (n=2) and those with a follow-up of <1 years (n=3) were excluded from the analysis of test characteristics. KaplanMeier survival analyses were used to analyse time to diagnosis according to the 2007 and 2012 IPMSSG consensus definitions. The time to diagnosis was compared using a log-rank test. Survival analysis included all patients with a first MRI with gadolinium and either the presence of a follow-up scan or a diagnosis of CDMS according to the 2010 McDonald MRI criteria.
RESULTS
Ninety-two children presented with a first demyelinating event between January 2007 and April 2013 and were eligible for this study. Eight patients were excluded because cerebral MRI was not acquired at onset (n=6 not at onset, n=2 only spinal cord MRI). One patient was excluded because the MRI was not of sufficient quality. One patient with monophasic ADS was excluded because of loss to follow-up within 2 years after onset. Eighty-two children were analysed of whom 41 were younger than 12 years at onset.
In table 1, patient characteristics, including sex, age at first onset of symptoms, type of onset, follow-up time in months and final diagnosis, are presented. CSF data are also presented in table 1, since the 2007 IPMSSG definitions incorporate CSF in the criteria for DIS, whereas CSF positivity is defined by either the presence of oligloclonal bands or an elevated IgG index. CDMS during current follow-up. Two of these patients have started DMT, which may have suppressed a second clinical event. Children with MS were older (F=18.35, p<0.001) and have a different type of onset (χ 2 =27.6, p<0.001) as compared with children with monophasic or other relapsing demyelinating disorders. None of the children currently diagnosed with MS presented with ADEM, as defined by a polyfocal event with encephalopathy. 1 Four patients were diagnosed with NMO according to both 2007 and 2012 consensus definitions. 1 10 Three of them suffered from a relapsing disease course. Anti-aquaporin-4 antibodies were tested in 39 patients (48%) as part of their diagnostic follow-up using a cell-based assay and fluorescence-activated cell sorter. 12 Two patients had anti-aquaporin-4 IgG seropositivity, one patient with recurrent NMO and one patient who presented with a brainstem syndrome and was diagnosed with NMO-related spectrum disorder. 13 Two patients had a final diagnosis of other relapsing demyelinating disorders: one patient suffered from relapsing optic neuritis (ON) in the absence of MRI lesions fulfilling DIT for MS diagnosis and aquaporin-4 antibodies for NMO spectrum diagnosis. The other patient suffered from a first event of ADEM followed by one event of ON without the presence of new MRI lesions during follow-up. 14 None of the children with ADEM onset had a subsequent event of ADEM (multiphasic ADEM).
In table 2, sensitivity and specificity of the 2007 and 2012 IPMSSG consensus definitions are presented with CDMS as endpoint using only the baseline characteristics and using also follow-up MRI.
The 2012 IPMSSG consensus definitions had better sensitivity (79% vs 68%), NPV (88% vs 71%) and accuracy (92% vs 82%) In a subgroup of 41 children younger than 12 years at onset, including four patients with MS, we found a lower sensitivity (50%) but higher NPV (95%) applying the 2010 McDonald MRI criteria, irrespective of the age limit at first MRI, but a high sensitivity (100%) when a follow-up MRI is included. Sixty-five children, including 24 children with MS, had a first MRI with gadolinium administration. MS was diagnosed in 14 (47%) children at first MRI (excluding two children younger than 12 years) using the 2012 IPMSSG definitions. Six (20%) of these patients had a spinal cord lesion contributing to DIS McDonald MRI criteria.
Twenty-seven children were eligible for the survival analysis. Kaplan-Meier survival curves (figure 1) show the time to MS diagnosis using the 2007 versus 2012 IPMSSG consensus definitions. MS diagnosis in children can be made significantly earlier (χ 2 =8.24, p=0.004) using the revised 2012 consensus definitions based on the 2010 McDonald MRI criteria, similar as in adults. 15 The mean time to diagnosis was 8.5±7.4 months and 5.1±7.2 months applying the 2007 and 2012 IPMSSG definitions, respectively (t=6.87, p<0.001). The average time to MS diagnosis is 3.4 months earlier using the 2012 IPMSSG definitions. The mean time to a second event defining CDMS was 10.1±8.7 months.
DISCUSSION
In this study, the revised 2012 IPMSSG consensus definitions for paediatric MS and immune-mediated CNS demyelinating disorders were evaluated in a prospective nationwide cohort of children aged 1.0-17.7 years old with the full spectrum of immune-mediated CNS demyelination disorders. The 2010 revised McDonald MRI criteria have already been studied and found useful in children with CNS demyelination. [4] [5] [6] [7] [8] In contrast to these previous studies, not only the revised 2010 McDonald MRI criteria were considered in the present study, but also other clinical characteristics as proposed in the 2012 IPMSSG definitions. This means that the 2010 McDonald MRI criteria for DIT on the first MRI can only be applied to children of 12 years and older and having a first clinical event not meeting criteria for ADEM. This study showed that the 2012 IPMSSG consensus definitions allow for an equally reliable, but earlier MS diagnosis in all children, also those younger than 12 years. Fourteen (47%) MS patients could be diagnosed at first MRI using the 2012 IPMSSG definitions. Six of these patients (20%) fulfilled DIS McDonald criteria because of the presence of spinal cord lesion(s), confirming the importance of a spinal cord MRI at onset. 7 An important finding in our study is that the final diagnosis corresponded applying either the 2007 or 2012 IPMSSG consensus definitions. However, using the 2012 definitions, a diagnosis of MS can be made earlier, which is beneficial for adequate counselling of the children and their families, as prognosis can be uncertain after ADS, and children with MS may benefit from early treatment.
Test characteristics were better when applying the 2012 IPMSSG definitions compared with the 2007 definitions. When including follow-up MRI scans for the application of the 2007 and 2012 IPMSSG definitions, both have a high specificity and PPV, indicating the absence of false-positive test results. This is because the McDonald MRI criteria do not apply for children aged ≥10 years (2007 IPMSSG definitions) and ≥12 years at baseline (2012 IPMSSG definitions) and for children with an onset of ADEM (2012 IPMSSG definitions). Test characteristics for DIT based on MRI criteria according to 2007 IPMSSG definitions were calculated for 39/77 patients with a follow-up scan ≥3 months after the onset of clinical symptoms. This may have introduced some bias as the decision to make a second MRI might not be fully independent of the initial observed disease activity.
When applying the 2010 McDonald MRI criteria to all children (regardless of age), test characteristics are comparable although sensitivity would be higher, due to the finding that two patients ≤12 years old with paediatric MS tested false negative. In a subgroup of children aged younger than 12 years old, we found lower sensitivity and NPV, indicating more falsenegative results. A second MRI increased the sensitivity. When the DIS and DIT 2010 criteria are not applied in children with ADEM at onset but regardless of age, high specificity and PPV were found, which might warrant exclusion of the age limit. Further investigation of the age limit is needed.
In contrast to the study of Sadaka et al, 4 we did not find 100% sensitivity and NPV for the 2010 McDonald MRI criteria. This is probably explained by the fact we did not use a standardised MRI protocol, including systematic frequent follow-up MRIs. Despite the lack of a systematic MRI protocol, we did find earlier MS diagnosis in the Dutch cohort which resembles general clinical practice.
We only included patients with a minimum follow-up of 2 years (unless they were diagnosed with MS based on MRI criteria within 2 years (n=3)) because the time interval between first and second attack in paediatric MS is typically less than 12 months. 16 17 Despite a relatively long follow-up, it still might be that patients currently defined as monophasic will experience relapses in future.
A first onset of ADEM is an important clinical parameter when using the 2012 consensus definitions. In our prospective cohort, none of the patients with a first onset of ADEM developed MS during follow-up, confirming its role as a negative predictor for MS. Using the 2012 consensus definitions, children with ADEM can be diagnosed with MS earlier if they experience a second non-ADEM event with new MRI lesions at least 3 months after onset. We did not have such patients in our current cohort. Relapse after ADEM typically occurs within 2 years after onset, but in a small subgroup can occur many years later. 1 Using the new 2012 consensus definitions for the diagnosis of paediatric MS, CSF analysis is not strictly needed. Although in clinical practice CSF analysis in children presenting with neurological symptoms is still of importance in order to exclude other diagnoses as infections and malignancies, 18 it should be further investigated if CSF analysis is of use in doubtful cases where MRI criteria have not been completely fulfilled.
The results of our prospective multicentre cohort show that the 2012 IPMSSG consensus definitions apply well for a reliable and early diagnosis of paediatric MS and ADS.
